MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia

Experimental Brain Research

Volumn 178, Issue 4, 2007, Pages 470-476

  Henriksson, Marie ^a   Stenman, Emelie ^a   Vikman, Petter ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Elk 1; ERK1 2; ET; Ischaemia; MCAO; MEK1 2; Receptor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; TRANSCRIPTION FACTOR ELK 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DECAPITATION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR INTRINSIC ACTIVITY; STROKE; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; BUTADIENES; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE CONTRACTION; NEUROLOGIC EXAMINATION; NITRILES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 34147181750     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-006-0753-7     Document Type: Article

References (42)

1. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 96:12866-12869
2. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
3. Asano T, Ikegaki I, Suzuki Y, Satoh S, Shibuya M (1989) Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345-1351
4. Barone FC, Globus MY, Price WJ, White RF, Storer BL, Feuerstein GZ, Busto R, Ohlstein EH (1994) Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 14:337-342
5. Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H (1986a) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308
6. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986b) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476
7. Bhardwaj A, Wu Y, Hurn PD, Kirsch JR, Traystman RJ (2000) Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat. J Cereb Blood Flow Metab 20:499-504
8. Chuquet J, Benchenane K, Toutain J, MacKenzie ET, Roussel S, Touzani O (2002) Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33:3019-3025
9. Dawson DA, Sugano H, McCarron RM, Hallenbeck JM, Spatz M (1999) Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem Res 24:1499-1505
10. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, Schulz R (2004) The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24:467-474
11. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632
12. Henriksson M, Stenman E, Edvinsson L (2003) Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 34:1479-1483
13. Henriksson M, Xu CB, Edvinsson L (2004) Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 142:1155-1161
14. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF (1985) Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 248:C550-C556
15. Högestätt ED, Andersson KE, Edvinsson L (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49-61
16. Iwasa S, Fan J, Shimokama T, Nagata M, Watanabe T (1999) Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146:93-100
17. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky M (1997) Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28:1951-1955
18. Lennmyr F, Karlsson S, Gerwins P, Ata KA, Terent A (2002) Activation of mitogen-activated protein kinases in experimental cerebral ischemia. Acta Neurol Scand 106:333-340
19. Leppa S, Saffrich R, Ansorge W, Bohmann D (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. Embo J 17:4404-4413
20. Li XS, Wang QD, Pernow J (1995) Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Eur J Pharmacol 283:161-168
21. Lodge NJ, Zhang R, Halaka NN, Moreland S (1995) Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle. Eur J Pharmacol 287:279-285
22. McAuley MA, Breu V, Graham DI, McCulloch J (1996) The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat. Eur J Pharmacol 307:171-181
23. Memezawa H, Minamisawa H, Smith ML, Siesjo BK (1992) Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 89:67-78
24. Memezawa H, Zhao Q, Smith ML, Siesjo BK (1995) Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res 670:48-52
25. Menzies SA, Hoff JT, Betz AL (1992) Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31:100-106; discussion 106-107
26. Miyauchi T, Goto K (1999) Heart failure and endothelin receptor antagonists. Trends Pharmacol Sci 20:210-217
27. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19-26
28. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA 98:11569-11574
29. Nilsson T, Cantera L, Adner M, Edvinsson L (1997) Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 40:346-351;discussion 351-343
30. Patel TR, Galbraith S, Graham DI, Hallak H, Doherty AM, McCulloch J (1996a) Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab 16:950-958
31. Patel TR, Galbraith S, McAuley MA, McCulloch J (1996b) Endothelin-mediated vascular tone following focal cerebral ischaemia in the cat. J Cereb Blood Flow Metab 16:679-687
32. Patel TR, Galbraith SL, McAuley MA, Doherty AM, Graham DI, McCulloch J (1995) Therapeutic potential of endothelin receptor antagonists in experimental stroke. J Cardiovasc Pharmacol 26(Suppl 3):S412-S415
33. Patel TR, McCulloch J (1996) Failure of an endothelin antagonist to modify hypoperfusion after transient global ischaemia in the rat. J Cereb Blood Flow Metab 16:490-499
34. Robinson MJ, Macrae IM, Todd M, Reid JL, McCulloch J (1990) Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 118:269-272
35. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735
36. Seger R, Krebs EG (1995) The MAPK signaling cascade. Faseb J 9:726-735
37. Stenman E, Edvinsson L (2004) Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35:970-974
38. Stenman E, Malmsjo M, Uddman E, Gido G, Wieloch T, Edvinsson L (2002) Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 33:2311-2316
39. Szok D, Hansen-Schwartz J, Edvinsson L (2001) In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci Lett 314:69-72
40. Umemura K, Ishiye M, Kosuge K, Nakashima M (1995) Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model. Eur J Pharmacol 275:17-21
41. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407
42. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M (1992) Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23:1014-1016